Garcia 2003.

Methods	Randomised, prospective trial
Participants	Cardiothoracic patients. Both carriers and non‐carriers. Mupirocin: 31 carriers, Placebo: 34 carriers. No significant difference between both groups.
Interventions	Mupirocin twice daily for 5 days. Controls received no treatment.
Outcomes	S. aureus infection rate.
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	High risk	Inadequate
Blinding? participants	High risk
Blinding? investigator	High risk
Intention to treat	Low risk	not reported but confirmed by author
Loss to follow up	Low risk	Mupirocin:13 Control:15